Pharma Finance and Investment News
Owlstone Medical Secures $6.5 Million to Support Development
Owlstone Medical have announced it has secured funding from the Bill & Melinda Gates Foundation. Read more
25 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Kühne Holding Acquires Aenova from BC Partners
Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organisation Aenova Group from leading international investment firm BC Partners. Read more
24 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Bristol Myers Squibb Signs $380 Million Deal with Cellares
Bristol Myers Squibb and Cellares have announced a worldwide capacity reservation and supply agreement for the manufacture of CAR T cell therapies in a transaction valued up to $380M in upfront and milestone payments. Read more
23 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Chiesi Group's 2023 Revenue Surpasses €3 Billion
In 2023, Chiesi reached over €3 billion in sales – a 10% growth (+12% @CER) on the previous year – maintaining an EBIDTA of approximately 30% for the fourth consecutive year. Read more
22 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
SeaBeLife Awarded Over €1.5 Million
SeaBeLife, a biotechnology company developing drug candidates intended to block cellular necrosis, have announced the award of more than €1.5M ($1.6M) in financing for its SeaBeEYE project at the i-Nov 2024 innovation competition. Read more
22 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Fujifilm to Invest Additional $1.2 Billion to Expand US Manufacturing Facility
FUJIFILM Corporation have announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina. Read more
16 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Dot Compliance Raises $17.5 Million in Series B Extension Funding
Dot Compliance, a provider of AI-enabled Quality Management System (QMS) solutions, have announced it has raised $17.5 million in Series B extension funding, marking a significant up-round. Read more
15 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Novartis Tender Offer for MorphoSys AG Commences
Novartis published the offer document for the voluntary public takeover offer by its wholly owned subsidiary Novartis BidCo AG for all outstanding shares of MorphoSys AG. Read more
12 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round
Seaport Therapeutics, a clinical-stage biopharmaceutical company that is charting a proven path in neuropsychiatry, have announced the closing of a $100 million oversubscribed Series A financing round. Read more
10 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Aramex Scoop Sustainability Award
Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Berry Global Invests to Increase Production Capacity
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Regeneron and Mammoth Biosciences to Collaborate
Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration to research, develop and commercialise in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Novartis Radioligand Therapy Lutathera FDA Approved
Novartis have announced that the FDA have approved Lutathera for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumours. Read more
25 Apr 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Owlstone Medical Secures $6.5 Million to Support Development
Owlstone Medical have announced it has secured funding from the Bill & Melinda Gates Foundation. Read more
25 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
MHRA Approves YORVIPATH
Ascendis Pharma have announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for YORVIPATH. Read more
25 Apr 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25